Although a decrease in all-cause mortality was observed with rifaximin use, this effect did not reach statistical significance in the adjusted analysis.
← all excerpts
Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy.
1
—
—